Abstract
For the month of February 2022, APBN looks at the many ways research is paving the way for improved cancer treatment outcomes. In Features, Kenneth Tan, President of Asia-Pacific, Japan and India at Varian, shares how we can accelerate the path from cancer diagnosis to therapy, improving survivorship. Then, Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, writes about the importance of cancer research, its challenges, and how the Foundation is working to support brain cancer research. For our last feature, we have Dr Ahmed Abdelal, Global Head Medical Affairs Interventional Imaging and North America Head of Medical & Regulatory Affairs, Guerbet and Dr Binta Patel, North America Medical Affairs Manager, Guerbet, to give us a treatment update for hepatocellular carcinoma. Other topics covered in this issue includes the importance of trust in the pharmaceutical industry and how companies can improve trust with technology-led transparency, how we may learn from the pandemic and better prepare for the next unknown crisis, a discussion on the incidence of Omicron and Delta variants in two case studies, and an interview with a spokesperson from Novartis on their newly approved cholesterol drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
